SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-022368
Filing Date
2019-04-30
Accepted
2019-04-30 16:05:55
Documents
7
Period of Report
2019-06-20
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv519111-def14a.htm DEF 14A 1075977
2 GRAPHIC lg_intercept-new.jpg GRAPHIC 42068
3 GRAPHIC sg_mark-pruzanski.jpg GRAPHIC 30118
4 GRAPHIC tv519111_chrt-performance.jpg GRAPHIC 60278
5 GRAPHIC tv519111_chrt-compensation.jpg GRAPHIC 65322
6 GRAPHIC tv519111_pc1.jpg GRAPHIC 587910
7 GRAPHIC tv519111_pc2.jpg GRAPHIC 390126
  Complete submission text file 0001144204-19-022368.txt   2663682
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 19781645
SIC: 2834 Pharmaceutical Preparations